Federica Zito Marino

Author

University of Campania "Luigi Vanvitelli"ORCID

Also Known As

F Zito Marino, Federica Zito Marino, Federica Zito-Marino, Federica Zitomarino, Gabriella Aquino, Marino, Federica Zito

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"University of Naples Federico II Ospedale Monaldi Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

About

Federica Zito Marino is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	336
2	Cell Biology	5	5	187
3	Natural Sciences	1	1	101
4	Biochemistry	1	1	101
5	Immunology	1	1	16

Federica Zito Marino

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, Cardiovascular Diabetology	2021	103
Golgi maturation‐dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3 Riccardo Rizzo, Domenico Russo, Kazuo Kurokawa, The EMBO Journal Protein GlycosylationBiosynthesisGlycosylationBiochemistryControls Glycosphingolipid Biosynthesis	2021	101
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells Federica Liotti, Narender Kumar, Nella Prevete, Journal of Experimental & Clinical Cancer Research	2021	82
Mitochondrial AKAP1 supports mTOR pathway and tumor growth Laura Rinaldi, Maria Sepe, Rossella Delle Donne, Cell Death and Disease Tumor BiologySystems BiologyMitochondrial FunctionMedicineTumor Growth	2017	58
Analysis of <scp>NSCLC</scp> tumour heterogeneity, proliferative and 18F‐<scp>FDG PET</scp> indices reveals Ki67 prognostic role in adenocarcinomas Alessandro Del Gobbo, Alessio Pellegrinelli, Gabriella Gaudioso, Histopathology	2015	55
New therapeutic perspectives in <scp>CCDC</scp>6 deficient lung cancer cells Francesco Morra, Chiara Luise, Roberta Visconti, International Journal of Cancer	2014	52
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer Claudia Cardone, Bernadette Blauensteiner, Verónica Moreno‐Viedma, European Journal of Cancer MedicinePathologyColorectal CancerAnti-egfr TherapyCancer Biology	2020	48
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer Carmine A. Nunziata, Andrea Polo, Angela Sorice, Scientific Reports	2019	46
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH Maria Cecilia Mengoli, Giulio Rossi, Alberto Cavazza, The American Journal of Surgical Pathology	2018	44
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma Carmela De Marco, Nicola Rinaldo, Paola Bruni, PLoS ONE Gene AmplificationAkt ActivationPathologyCancer BiologyTumor Biology	2013	40

Page 1